醫揚科技股份有限公司 Approved
最後更新時間 2025/07/18 , 07:18 AM
最後更新時間 2025/07/18 , 07:18 AM
負責人
Zhuang,Yong-Shun
統一編號
29135647
成立日期
2010/02/02
資本額
NT$1,000,000,000
實收資本額
NT$390,147,450
股票代號
6569
電話
366
地址
4F, No. 135, Ln. 235, Baociao Rd., Xindian Dist., New Taipei City, 231, Taiwan
董監事
姓名 職稱 持有股份 代表法人
Zhuang,Yong-Shun Chairman 0.65% RUI HAI INVESTMENT CO., LTD.
Zhuang,Fu-Jun Director 0.65% RUI HAI INVESTMENT CO., LTD.
Lai,Li-Kai Director 47.92% AAEON TECHNOLOGY INC.
Xue,Shao-Zhou Director 47.92% AAEON TECHNOLOGY INC.
Li,Zhi-Hao Independent Director 0.00%
Ceng,He-Qun Independent Director 0.17%
Liao,Xiu-Mei Independent Director 0.00%
Lin,Shang-Wei Independent Director 0.00%
營業項目
  • Manufacture of Other Electronic Parts and Components Not Elsewhere Classified(269999)
  • Manufacture of Other Computer Peripheral Equipment(271999)
  • Manufacture of Other Medical Instruments and Supplies(332900)
  • 公司歷程
  • Change Capital to 500,000,000
    2019/06/11
  • Change Capital to 250,000,000
    2016/08/17
  • Change Capital to 150,000,000
    2014/08/22
  • 員工人數
    下載完整報告查看完整數據
    財務報表
    項目 2025 2024 2023
    Operating income 309,941 1,241,251 1,492,860
    Operating cost 217,435 784,976 936,716
    Profit (loss) of initial recognition of biological asset and agricultural products - - -
    Profit (loss) on changes in fair value less costs to sell of biological asset for current period - - -
    Operating gross profit (loss) 92,506 456,275 556,144
    Unrealized profit (loss) on sales of goods - - -
    Realized profit (loss) on sales of goods - - -
    Operating gross profit (loss), net 92,506 456,275 556,144
    Operating expenses 99,131 367,547 338,022
    Other gain (loss), net - - -
    Operating profit (loss) -6,625 88,728 218,122
    Non-operating income and expenses 12,754 117,679 86,878
    Net profit (loss) before tax 6,129 206,407 305,000
    Income tax expense (benefits) -1,226 26,282 49,830
    Net profit (loss) of ongoing business for the current period 7,355 180,125 255,170
    Profit (loss) of closed units - - -
    Profit (loss) of non-jointly controlled equity before merger - - -
    Net profit (loss) for the current period 7,355 180,125 255,170
    Other comprehensive profit (loss), net 8,832 9,862 -1,088
    Comprehensive net profit and loss of non-jointly controlled equity before merger - - -
    Total comprehensive profit and loss for the current period 16,187 189,987 254,082
    Net profit (loss) attributable to owners of parent company 7,394 180,914 255,262
    Net profit (loss) form equity attributable to former owner of business combination under common control - - -
    Net profit (loss) attributable to non-controlling interests -39 -789 -92
    Comprehensive profit (loss) attributable to owners of parent company 16,226 190,776 254,174
    Comprehensive profit (loss) form equity attributable to former owner of business combination under common control - - -
    Comprehensive profit (loss) attributable to non-controlling interests -39 -789 -92
    Basic earnings per share (yuan) 0 4 7
    項目 2025 2024 2023
    Net cash inflow (outflow) from operating activities 42,701 124,516 350,493
    Net cash inflows (outflows) from investing activities -5,650 -52,975 -184,357
    Net cash inflow (outflow) from financing activities -47,273 -120,669 -128,537
    Effect of Exchange Rate Changes on Cash and Cash Equivalents 4,397 6,954 282
    Increase (decrease) in cash and cash equivalents in the current period -5,825 -42,174 37,881
    Beginning balance of cash and cash equivalents 324,593 366,767 328,886
    Ending balance of cash and cash equivalents 318,768 324,593 366,767
    項目 2025 2024 2023
    Current asset 808,191 824,607 870,965
    Non-current asset 1,296,980 1,281,586 1,177,243
    Total asset 2,105,171 2,106,193 2,048,208
    Current liability 290,218 338,864 305,151
    Non-current liability 209,592 214,571 222,511
    Total liability 499,810 553,435 527,662
    share capital 390,147 386,277 335,163
    Equity - secruity token - - -
    capital reserve 750,316 717,770 708,803
    retained earning 468,247 460,853 497,795
    Other equity -11,475 -20,307 -30,169
    Treasury stock - - -
    Total equity attributable to owners of parent company 1,597,235 1,544,593 1,511,592
    Equity attributable to former owner of business combination under common control - - -
    Equity attributable to non-controlling interest before business merger under common control - - -
    Non-controlling interests 8,126 8,165 8,954
    Total Equity 1,605,361 1,552,758 1,520,546
    Share capital awaiting retirement (unit: share) 0 0 0
    Issued shares of advance equity (unit: shares) 0 0 0
    Treasury shares of the parent company held by the parent company and its subsidiaries (unit: share) 0 0 0
    Net asset value per share 40 39 45
    動產抵押
    下載完整報告查看完整數據
    案件類別 債務人名稱 債務人統編 契約啟始日期 契約終止日期 抵押權人名稱 抵押權人統編 擔保債權金額
    選舉收入(政治獻金)
    收入名稱 收入金額
    總收入金額
    選舉支出(政治獻金)
    支出名稱 支出金額
    總支出金額
    標案拒往
    機關名稱 生效日期 截止日期
    進出口資料
    下載完整報告查看完整數據
    年份 月份 總進口實績(美金) 總出口實績(美金)
    商標
  • MEDLINC
  • 醫揚
  • onyx Smart Healthcare
  • 專利
    政府標案
    標案名稱 機關名稱 決標日期 決標金額 是否得標
    裁判書查詢
    勞權違規
    日期 違反法規法條 罰鍰金額
    污染源裁處
    污染類別 裁處時間 裁處機關 裁處金額 違反事實 違反法令 裁處書字號 裁處理由及法令 公司地址
    本頁內所載之資料,所載資料之完整性、即時性和正確性仍應以資料來源單位為準。
    公司一有新動態,我們馬上通知你,追蹤公司讓你不錯過任何更新。